In contrast to the intestinal subtype, no significant modulation of PD-L1 expression was observed in diffuse GC vs. peri-tumoral samples (no overexpression and no change with clinical parameters) (Table 2, Table 3 and Table S1). This evidence concerns the gene CD274 and gastric cancer.